Macrophage migration inhibitory factor (MIF) is a pleiotrophic lymphocyte and macrophage cytokine; it is likely to play an important role in innate immunity. Genome-wide search for atopy susceptibility genes recently identified human chromosome 22q11, where the gene encoding MIF resides, as a region of interest for atopic traits. Both the Ϫ173G/C and Ϫ794 [CATT] 5-8 repeat polymorphisms in the MIF promoter region are associated with altered levels of MIF gene transcription in vitro. We, therefore, hypothesized that these potentially functional polymorphisms may influence susceptibility to atopy and asthma. A case-control analysis examined the genetic influence of these promoter polymorphisms on the development of atopy and asthma in a Japanese population (n ϭ 584). Evidence for significant association between the Ϫ173G/C and Ϫ794 [CATT] 5-8 repeat polymorphisms and atopy was found; odds ratio for homozygotes of Ϫ173C allele was 3.67 (compared with homozygotes of Ϫ173G allele, 95% confidence interval ϭ 1.43-9.46, p Ͻ 0.01), and odds ratio for noncarriers of the Ϫ794 [5-CATT] allele was 3.51 (compared with 5-CATT repeat homozygotes, 95% confidence interval ϭ 1.82-6.78, p Ͻ 0.0005). No associations with asthma were detected. These results indicate that promoter polymorphisms in the MIF promoter region are risk factors for atopy and implicate MIF in the pathogenesis of atopy in a Japanese population.
Keywords: candidate gene; case-control analysis; specific IgEMacrophage migration inhibitory factor (MIF) was initially described as an immune activity isolated from the supernatants of T lymphocytes (1) and has been implicated in macrophage activation and in antigen-driven T cell responses (2, 3). A recent investigation indicated that MIF regulates innate immune responses by macrophages through modulation of expression of toll-like receptor 4 (4); toll-like receptor 4 is the principal receptor for bacterial endotoxin recognition. There is evidence that endotoxin exposure during early life is protective against development of atopy and asthma (5-7); it is hypothesized that bacterial signals, such as endotoxin, play a functional role in maturation of T helper cell type (Th) 1-type immune responses, suppressing the Th2 response (8).We previously demonstrated expression of MIF protein in serum and induced sputum of patients with asthma (9). Bronchoalveolar lavage fluid obtained from patients with asthma having atopy also contains significantly elevated levels of MIF, compared with volunteers not having atopy (10). Furthermore,